» Articles » PMID: 36278522

Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients

Overview
Journal Hematol Rep
Publisher MDPI
Date 2022 Oct 24
PMID 36278522
Authors
Affiliations
Soon will be listed here.
Abstract

Patients affected by transfusion-dependent β-thalassemia are prone to developing several clinical complications, mostly related to the iron overload. We report the case of a patient affected by transfusion-dependent β-thalassemia (TDT) developing acute promyelocytic leukemia (APL). In our case, the therapeutic management was significantly complicated not only by myocardial dysfunction, but also by the occurrence of the differentiation syndrome following all-trans retinoic acid (ATRA) administration. We carried out a careful revision of the current literature on the occurrence of hematological malignancies in β-thalassemia patients to investigate the major complications so far described. APL occurrence in β-thalassemia patients has been very rarely reported, and our experience suggests that TDT patients suffering pre-existing comorbidities may develop a potentially fatal complication during ATRA therapy.

Citing Articles

Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives.

Li Z, Yao X, Zhang J, Yang J, Ni J, Wang Y Front Immunol. 2024; 15:1403458.

PMID: 39161767 PMC: 11330836. DOI: 10.3389/fimmu.2024.1403458.


Genome-wide methylation and gene-expression analyses in thalassemia.

Zhang W, Li X, Yu U, Huang X, Wang H, Lu Y Aging (Albany NY). 2024; 16(15):11591-11605.

PMID: 39133159 PMC: 11346785. DOI: 10.18632/aging.206037.

References
1.
Siwaponanan P, Siegers J, Ghazali R, Ng T, McColl B, Ng G . Reduced PU.1 expression underlies aberrant neutrophil maturation and function in β-thalassemia mice and patients. Blood. 2017; 129(23):3087-3099. DOI: 10.1182/blood-2016-07-730135. View

2.
Leblebjian H, DeAngelo D, Skirvin J, Stone R, Wadleigh M, Werner L . Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia. Leuk Res. 2013; 37(7):747-51. DOI: 10.1016/j.leukres.2013.04.011. View

3.
Mueller B, Pabst T, Fos J, Petkovic V, Fey M, Asou N . ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood. 2005; 107(8):3330-8. PMC: 1895760. DOI: 10.1182/blood-2005-07-3068. View

4.
Di Noto R, Pardo C, Schiavone E, Ferrara F, Manzo C, Vacca C . All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma. 1996; 21(3-4):201-9. DOI: 10.3109/10428199209067601. View

5.
Voskaridou E, Terpos E, Komninaka V, Eftyhiadis E, Mantzourani M, Loukopoulos D . Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide. Br J Haematol. 2002; 116(1):155-7. DOI: 10.1046/j.1365-2141.2002.03241.x. View